Focus on Ocular Health

AREDS2 Results: Translation and Incorporation into Patient Management of Macular Degeneration (AMD)

May 19, 201427 min
Hosted by: Lee Freedman
Guest: MItchell S. Fineman
Macular Degeneration, also referred to as AMD, is the leading cause of blindness in the developed world, and accounts for more than 50% of all blindness in the United States. In May 2013, the National Eye Institute (NEI) completed the Age-Related Eye Disease Study 2, which tested several changes to the original supplement formulation created as a result of the original AREDS study.
Host Dr. Lee Freedman welcomes Dr. Mitchell Fineman,  Associate Surgeon at Wills Eye Institute and Associate Professor of Ophthalmology at Jefferson Medical School of Thomas Jefferson University Hospital. Dr. Fineman will discuss AMD, treatment options and the focus on macular vitamin products.
View Dr Fineman's webinar.

Chat About AREDS2 Results: Translation and Incorporation into Patient Management of Macular Degeneration (AMD)

For You